Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:amino cyclitol
go back to main search page
Accession:CHEBI:61689 term browser browse the term
Definition:Any cyclitol having one or more alcoholic hydroxy groups replaced by substituted or unsubstituted amino groups.
Synonyms:related_synonym: amino cyclitols;   aminocyclitol;   aminocyclitols


show annotations for term's descendants       view all columns           Sort by:
 
isepamicin term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Pgd phosphogluconate dehydrogenase JBrowse link 5 165,966,128 165,982,327 RGD:6480464
G Pkd2 polycystin 2, transient receptor potential cation channel JBrowse link 14 6,602,004 6,645,257 RGD:6480464
netilmycin term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Pgd phosphogluconate dehydrogenase JBrowse link 5 165,966,128 165,982,327 RGD:6480464
paromomycin term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Atm ATM serine/threonine kinase JBrowse link 8 58,015,938 58,119,973 RGD:6480464
streptomycin term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Hoxb9 homeo box B9 JBrowse link 10 84,119,772 84,124,963 RGD:6480464
G Pax3 paired box 3 JBrowse link 9 84,004,004 84,101,226 RGD:6480464
G Tcf15 transcription factor 15 JBrowse link 3 147,643,250 147,649,511 RGD:6480464
G Tnf tumor necrosis factor JBrowse link 20 5,189,382 5,192,000 RGD:6480464
G Uncx UNC homeobox JBrowse link 12 17,182,158 17,186,679 RGD:6480464

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19791
    chemical entity 19790
      molecular entity 19788
        polyatomic entity 19698
          heteroatomic molecular entity 19616
            hydroxides 19080
              organic hydroxy compound 18645
                polyol 7781
                  cyclitol 2452
                    amino cyclitol 8
                      (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]-2-oxanyl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2R,3R,6S)-3-amino-6-(aminomethyl)-2-oxanyl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2R,3R,6S)-3-amino-6-[(1R)-1-(methylamino)ethyl]-2-oxanyl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol 0
                      (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol 0
                      (2R,3R,4S,5S,6S)-2-[[(3S,4R,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol 0
                      (2R,4S,5S)-2-[[(2R,6S,8aS)-7-amino-6-[(2R,4R)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol 0
                      (2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2R,3R,6S)-3-amino-6-[1-(methylamino)ethyl]-2-oxanyl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol 0
                      (2S,3R,4S,5S)-2-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol 0
                      1-amino-1-deoxy-scyllo-inositol 0
                      2-[(1S,2S,3R,4S,5S,6R)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine 0
                      2-deoxy-scyllo-inosamine 0
                      2-deoxystreptamine + 0
                      2-deoxystreptamine derivative + 0
                      2-deoxystreptidine 0
                      2-epi-Streptamine 0
                      3-Keto-scyllo-inosamine 0
                      5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[[(2S,3S,4S)-4-[(3-amino-4,5-dihydroxy-2-oxanyl)methoxymethyl]-3-hydroxy-2-oxolanyl]oxy]-3-hydroxycyclohexyl]oxyoxane-3,4-diol 0
                      Actinamine 0
                      Bluensidine 0
                      Destomysin 0
                      Fortimicin KL1 0
                      HS44 0
                      LSM-6702 0
                      LSM-6706 0
                      N3'-Acetylapramycin 0
                      Streptomycin B 0
                      bacteriohopanetetrol cyclitol ether 0
                      desoxymycin 0
                      etimicin 0
                      neo-Inosamine-2 0
                      streptamine + 3
                      streptidine + 5
                      validamine + 0
                      validamine 7-phosphate 0
                      validoxylamine A 0
                      validoxylamine A 7'-phosphate 0
                      validoxylamine B 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19791
    subatomic particle 19789
      composite particle 19789
        hadron 19789
          baryon 19789
            nucleon 19789
              atomic nucleus 19789
                atom 19789
                  main group element atom 19675
                    p-block element atom 19675
                      p-block molecular entity 19675
                        chalcogen molecular entity 19379
                          oxygen molecular entity 19340
                            hydroxides 19080
                              organic hydroxy compound 18645
                                polyol 7781
                                  cyclitol 2452
                                    amino cyclitol 8
                                      (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2R,3R,6S)-3-amino-6-[(1R)-1-aminoethyl]-2-oxanyl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2R,3R,6S)-3-amino-6-(aminomethyl)-2-oxanyl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2R,3R,6S)-3-amino-6-[(1R)-1-(methylamino)ethyl]-2-oxanyl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol 0
                                      (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol 0
                                      (2R,3R,4S,5S,6S)-2-[[(3S,4R,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol 0
                                      (2R,4S,5S)-2-[[(2R,6S,8aS)-7-amino-6-[(2R,4R)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol 0
                                      (2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2R,3R,6S)-3-amino-6-[1-(methylamino)ethyl]-2-oxanyl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol 0
                                      (2S,3R,4S,5S)-2-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[[3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol 0
                                      1-amino-1-deoxy-scyllo-inositol 0
                                      2-[(1S,2S,3R,4S,5S,6R)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine 0
                                      2-deoxy-scyllo-inosamine 0
                                      2-deoxystreptamine + 0
                                      2-deoxystreptamine derivative + 0
                                      2-deoxystreptidine 0
                                      2-epi-Streptamine 0
                                      3-Keto-scyllo-inosamine 0
                                      5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[[(2S,3S,4S)-4-[(3-amino-4,5-dihydroxy-2-oxanyl)methoxymethyl]-3-hydroxy-2-oxolanyl]oxy]-3-hydroxycyclohexyl]oxyoxane-3,4-diol 0
                                      Actinamine 0
                                      Bluensidine 0
                                      Destomysin 0
                                      Fortimicin KL1 0
                                      HS44 0
                                      LSM-6702 0
                                      LSM-6706 0
                                      N3'-Acetylapramycin 0
                                      Streptomycin B 0
                                      bacteriohopanetetrol cyclitol ether 0
                                      desoxymycin 0
                                      etimicin 0
                                      neo-Inosamine-2 0
                                      streptamine + 3
                                      streptidine + 5
                                      validamine + 0
                                      validamine 7-phosphate 0
                                      validoxylamine A 0
                                      validoxylamine A 7'-phosphate 0
                                      validoxylamine B 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.